Ronald B Rowley

Title: The Innovative Contributions of Ronald B Rowley

Introduction

Ronald B Rowley is a notable inventor based in Guilford, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of transgenic non-human mammals. His work focuses on advancing medical research and treatment options for cancer.

Latest Patents

Rowley holds a patent for "Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors." This invention involves a transgenic non-human mammal whose germ cells and somatic cells contain a constructively activated tyrosine kinase receptor introduced at an embryonic stage. These transgenic mammals serve as ligand-independent in vivo models for identifying and developing selective tyrosine kinase modulators for cancer treatment.

Career Highlights

Rowley is associated with Bristol-Myers Squibb Company, where he applies his expertise in biotechnology and genetics. His innovative work has the potential to impact cancer research significantly, providing new avenues for therapeutic development.

Collaborations

Some of his notable coworkers include David K Bol and Joan Carboni, who contribute to the collaborative efforts in advancing research and development within the company.

Conclusion

Ronald B Rowley's contributions to biotechnology and cancer research through his innovative patents and collaborations highlight the importance of transgenic models in medical advancements. His work continues to pave the way for future discoveries in the treatment of cancer.